{"id":1326,"date":"2025-01-08T13:45:38","date_gmt":"2025-01-08T13:45:38","guid":{"rendered":"https:\/\/amm-journal.org\/?p=1326"},"modified":"2025-01-08T13:45:38","modified_gmt":"2025-01-08T13:45:38","slug":"kinase-inhibitors","status":"publish","type":"post","link":"https:\/\/amm-journal.org\/index.php\/2025\/01\/08\/kinase-inhibitors\/","title":{"rendered":"Application of a macrocyclization strategy in kinase inhibitor development"},"content":{"rendered":"

Announcing a new publication for Acta Materia Medica<\/em> journal<\/a>. Kinases have a pivotal role in phosphorylation and kinase dysregulation has been implicated in the occurrence and progression of various diseases. By mid-2024 the Food and Drug Administration had approved 81 small-molecule kinase inhibitors targeting greater than 30 kinases, providing substantial clinical benefits for patients with cancer and other diseases. However, many reported kinase inhibitors exhibit poor target selectivity, limited solubility, and issues with drug resistance.<\/p>\n

To address these challenges medicinal chemists have used a macrocyclization strategy to optimize these molecules and three macrocyclic kinase inhibitors (lorlatinib [ALK\/ROS1], pacritinib [Flt3\/JAK2], and repotrectinib [TRK\/ROS1]) have received FDA approval. The macrocyclization strategy is now widely used to enhance kinase inhibitory activity, overcome drug resistance caused by point mutations, improve kinase selectivity, and optimize drug-like properties.<\/p>\n

In this review the authors comprehensively review the utilization of macrocyclization in the optimization of kinase inhibitors by detailing the structural modification process from lead compounds to macrocyclic molecules that has been applied in recent years. In addition, the limitations of existing macrocyclic kinase inhibitors are discussed and key considerations for the development of improved macrocyclic molecules are proposed. This review offers valuable insights for future advances in kinase inhibitor development.<\/p>\n

Read Open Access Articles at Scienceopen<\/a>:\u00a0https:\/\/www.scienceopen.com\/hosted-document?doi=10.15212\/AMM-2024-0070<\/a><\/p>\n

Acta Materia Medica<\/em> welcomes the submission of research articles, review articles, databases, mini reviews, commentaries, editorials, short communications, case report articles and study protocols.<\/p>\n

Submission Process<\/strong><\/p>\n

Submissions to Acta Materia Medica<\/em> are made using ScholarOne, the online submission and peer review system. Registration and access are available at https:\/\/mc04.manuscriptcentral.com\/ammed<\/a><\/p>\n

Queries about the journal can be sent to editorialoffice@amm-journal.org.<\/p>\n

Please visit https:\/\/amm-journal.org\/<\/a> to learn more about the journal.<\/p>\n

Editorial Board:<\/strong> https:\/\/amm-journal.org\/index.php\/editorial-board\/<\/a><\/p>\n

There are no author submission or article processing fees.<\/p>\n

Follow Acta Materia Medica <\/em><\/strong>on Twitter https:\/\/twitter.com\/AMM_journal<\/a>; Facebook<\/a> (https:\/\/www.facebook.com\/AMMjournal<\/a>)<\/p>\n

eISSN <\/strong>2737-7946<\/p>\n

Kun Xing, Shujun Li and Jinghuan Li et al. Application of a macrocyclization strategy in kinase inhibitor development.\u00a0Acta Materia Medica.\u00a0<\/em>2025. Vol. 3(4):521-555. DOI: 10.15212\/AMM-2024-0070<\/p>\n","protected":false},"excerpt":{"rendered":"

Announcing a new publication for Acta Materia Medica journal. Kinases have a pivotal role in phosphorylation and kinase dysregulation has been implicated in the occurrence and progression of various diseases. By mid-2024 the Food and Drug Administration had approved 81 small-molecule kinase inhibitors targeting greater than 30 kinases, providing substantial clinical benefits for patients with […]<\/p>\n","protected":false},"author":5,"featured_media":1327,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[379,378,381,376,380,377],"class_list":["post-1326","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-and-events","tag-binding-affinity","tag-drug-design","tag-drug-like-properties","tag-kinase-inhibitor","tag-kinase-selectivity","tag-macrocyclization-strategy"],"yoast_head":"\nApplication of a macrocyclization strategy in kinase inhibitor development<\/title>\n<meta name=\"description\" content=\"Explore how macrocyclization enhances kinase inhibitors, improving selectivity, overcoming resistance, and optimizing drug-like properties.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/amm-journal.org\/index.php\/2025\/01\/08\/kinase-inhibitors\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Application of a macrocyclization strategy in kinase inhibitor development\" \/>\n<meta property=\"og:description\" content=\"Explore how macrocyclization enhances kinase inhibitors, improving selectivity, overcoming resistance, and optimizing drug-like properties.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/amm-journal.org\/index.php\/2025\/01\/08\/kinase-inhibitors\/\" \/>\n<meta property=\"og:site_name\" content=\"AMM Journal\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-08T13:45:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/amm-journal.org\/wp-content\/uploads\/2025\/01\/Application.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2178\" \/>\n\t<meta property=\"og:image:height\" content=\"888\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Suresh PDMR\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Suresh PDMR\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/08\\\/kinase-inhibitors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/08\\\/kinase-inhibitors\\\/\"},\"author\":{\"name\":\"Suresh PDMR\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/36ab5fda177218467d112d0c1283065e\"},\"headline\":\"Application of a macrocyclization strategy in kinase inhibitor development\",\"datePublished\":\"2025-01-08T13:45:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/08\\\/kinase-inhibitors\\\/\"},\"wordCount\":364,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/08\\\/kinase-inhibitors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/amm-journal.org\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Application.jpg\",\"keywords\":[\"Binding affinity\",\"Drug design\",\"Drug-like properties\",\"Kinase inhibitor\",\"Kinase selectivity\",\"Macrocyclization strategy\"],\"articleSection\":[\"News and Events\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/08\\\/kinase-inhibitors\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/08\\\/kinase-inhibitors\\\/\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/08\\\/kinase-inhibitors\\\/\",\"name\":\"Application of a macrocyclization strategy in kinase inhibitor development\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/08\\\/kinase-inhibitors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/08\\\/kinase-inhibitors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/amm-journal.org\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Application.jpg\",\"datePublished\":\"2025-01-08T13:45:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/36ab5fda177218467d112d0c1283065e\"},\"description\":\"Explore how macrocyclization enhances kinase inhibitors, improving selectivity, overcoming resistance, and optimizing drug-like properties.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/08\\\/kinase-inhibitors\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/08\\\/kinase-inhibitors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/08\\\/kinase-inhibitors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Application.jpg\",\"contentUrl\":\"https:\\\/\\\/amm-journal.org\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Application.jpg\",\"width\":2178,\"height\":888},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/08\\\/kinase-inhibitors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/amm-journal.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Application of a macrocyclization strategy in kinase inhibitor development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#website\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/\",\"name\":\"AMM Journal\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/amm-journal.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/36ab5fda177218467d112d0c1283065e\",\"name\":\"Suresh PDMR\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g\",\"caption\":\"Suresh PDMR\"},\"url\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/author\\\/suresh\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Application of a macrocyclization strategy in kinase inhibitor development","description":"Explore how macrocyclization enhances kinase inhibitors, improving selectivity, overcoming resistance, and optimizing drug-like properties.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/amm-journal.org\/index.php\/2025\/01\/08\/kinase-inhibitors\/","og_locale":"en_GB","og_type":"article","og_title":"Application of a macrocyclization strategy in kinase inhibitor development","og_description":"Explore how macrocyclization enhances kinase inhibitors, improving selectivity, overcoming resistance, and optimizing drug-like properties.","og_url":"https:\/\/amm-journal.org\/index.php\/2025\/01\/08\/kinase-inhibitors\/","og_site_name":"AMM Journal","article_published_time":"2025-01-08T13:45:38+00:00","og_image":[{"width":2178,"height":888,"url":"https:\/\/amm-journal.org\/wp-content\/uploads\/2025\/01\/Application.jpg","type":"image\/jpeg"}],"author":"Suresh PDMR","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Suresh PDMR","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/08\/kinase-inhibitors\/#article","isPartOf":{"@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/08\/kinase-inhibitors\/"},"author":{"name":"Suresh PDMR","@id":"https:\/\/amm-journal.org\/#\/schema\/person\/36ab5fda177218467d112d0c1283065e"},"headline":"Application of a macrocyclization strategy in kinase inhibitor development","datePublished":"2025-01-08T13:45:38+00:00","mainEntityOfPage":{"@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/08\/kinase-inhibitors\/"},"wordCount":364,"commentCount":0,"image":{"@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/08\/kinase-inhibitors\/#primaryimage"},"thumbnailUrl":"https:\/\/amm-journal.org\/wp-content\/uploads\/2025\/01\/Application.jpg","keywords":["Binding affinity","Drug design","Drug-like properties","Kinase inhibitor","Kinase selectivity","Macrocyclization strategy"],"articleSection":["News and Events"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/amm-journal.org\/index.php\/2025\/01\/08\/kinase-inhibitors\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/08\/kinase-inhibitors\/","url":"https:\/\/amm-journal.org\/index.php\/2025\/01\/08\/kinase-inhibitors\/","name":"Application of a macrocyclization strategy in kinase inhibitor development","isPartOf":{"@id":"https:\/\/amm-journal.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/08\/kinase-inhibitors\/#primaryimage"},"image":{"@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/08\/kinase-inhibitors\/#primaryimage"},"thumbnailUrl":"https:\/\/amm-journal.org\/wp-content\/uploads\/2025\/01\/Application.jpg","datePublished":"2025-01-08T13:45:38+00:00","author":{"@id":"https:\/\/amm-journal.org\/#\/schema\/person\/36ab5fda177218467d112d0c1283065e"},"description":"Explore how macrocyclization enhances kinase inhibitors, improving selectivity, overcoming resistance, and optimizing drug-like properties.","breadcrumb":{"@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/08\/kinase-inhibitors\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/amm-journal.org\/index.php\/2025\/01\/08\/kinase-inhibitors\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/08\/kinase-inhibitors\/#primaryimage","url":"https:\/\/amm-journal.org\/wp-content\/uploads\/2025\/01\/Application.jpg","contentUrl":"https:\/\/amm-journal.org\/wp-content\/uploads\/2025\/01\/Application.jpg","width":2178,"height":888},{"@type":"BreadcrumbList","@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/08\/kinase-inhibitors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/amm-journal.org\/"},{"@type":"ListItem","position":2,"name":"Application of a macrocyclization strategy in kinase inhibitor development"}]},{"@type":"WebSite","@id":"https:\/\/amm-journal.org\/#website","url":"https:\/\/amm-journal.org\/","name":"AMM Journal","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/amm-journal.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/amm-journal.org\/#\/schema\/person\/36ab5fda177218467d112d0c1283065e","name":"Suresh PDMR","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g","caption":"Suresh PDMR"},"url":"https:\/\/amm-journal.org\/index.php\/author\/suresh\/"}]}},"_links":{"self":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/1326","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/comments?post=1326"}],"version-history":[{"count":1,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/1326\/revisions"}],"predecessor-version":[{"id":1328,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/1326\/revisions\/1328"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/media\/1327"}],"wp:attachment":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/media?parent=1326"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/categories?post=1326"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/tags?post=1326"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}